|
|||||
|
|
The efficacy of oral lumenoscopy™ (ViziLite®) in visualizing oral mucosal lesions |
|
| Authors: | Joel B. Epstein DMD MSD FRCD Meir Gorsky DMD Stewart Lonky MD Sol Silverman Jr. DDS MA Joshua D. Epstein MA Mark Bride DDS |
| Affiliation: | College of Dentistry and Illinois Cancer Center, University of Illinois, Chicago, 111., formerly British Columbia Cancer Agency, Vancouver, British Columbia;School of Dentistry, Tel Aviv University, Tel Aviv, Israel, Visiting Professor College of Dentistry, University of Illinois Chicago, 111;University of California, Los Angeles, School of Medicine and Trylon Corp Los Angeles, Calif;University of California, San Francisco Calif;Pharmaceutical Economics, University of Southern California, Los Angeles, Calif;Director, Medical Affairs Zila Pharmaceuticals, Phoenix, Ariz |
| Abstract: | Early diagnosis of oral mucosal lesions has been advocated as a means of improving outcomes of cancer therapy. Improved visualization of mucosal lesion* may aid in diagnosis by guiding tinue sampling or referral. This multi‐center study reports the effect of chemiluminescent light (ViziLite) upon visualization of mucosal lesions. The cftemiluminescent light did not appear to improve visualization of red lesions, but white lesions and lesions that were both red and white showed enhanced brightness and sharpness. |
| Keywords: | leukoplakia oral premalignant lesions squamous cell carcinoma early detection |